Related Experiment Video
Updated: Jan 31, 2026
Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
Published on: September 25, 2014
Pediatric cases caused by Streptococcus pneumoniae Serotype 3
Aslinur Ozkaya-Parlakay1, Meltem Polat2, Belgin Gulhan1
1a Pediatric Infectious Diseases Unit , Health Sciences University Ankara Hematology and Oncology Research Hospital , Ankara , Turkey.
Insights
Streptococcus pneumoniae causes invasive pneumococcal disease (IPD). High vaccination coverage and surveillance are crucial to reduce both vaccine and non-vaccine serotype carriage and track evolving pneumococcal epidemiology.
Area of Science:
- Microbiology
- Epidemiology
- Public Health
Background:
- Streptococcus pneumoniae is a significant global cause of invasive pneumococcal disease (IPD), contributing to substantial morbidity and mortality.
- While non-vaccine serotypes are a concern, serotypes covered by the 13-valent pneumococcal conjugate vaccine (PCV13) also remain problematic.
Purpose of the Study:
- To highlight the ongoing challenges posed by both vaccine and non-vaccine serotypes of Streptococcus pneumoniae in IPD.
- To emphasize the importance of high vaccination coverage and multicenter surveillance for controlling pneumococcal disease.
Main Methods:
- The study reviews current epidemiological data on IPD.
- It discusses the impact of existing vaccination strategies (PCV13) on serotype prevalence.
- It advocates for enhanced surveillance systems.
Main Results:
- Despite PCV13, certain vaccine serotypes continue to cause IPD.
- Non-vaccine serotypes represent a persistent challenge in pneumococcal epidemiology.
- High vaccination coverage is essential for reducing overall pneumococcal carriage.
Conclusions:
- Sustained high vaccination coverage is necessary to decrease carriage of both vaccine and non-vaccine pneumococcal serotypes.
- Multicenter surveillance studies are vital for monitoring shifts in pneumococcal seroepidemiology and guiding public health interventions.
Abstract:
Streptococcus pneumoniae causes invasive pneumococcal disease (IPD), leading to high morbidity and mortality worldwide. Although nonvaccine serotypes constitute a major issue in the aspect of invasive pneumococcal disease, serotypes included in PCV13 still continue to be a problem. Vaccination with very high coverage and multicenter surveillance studies would be beneficial to decrease carriage of vaccine and nonvaccine serotypes of pneumococcus and monitor changing seroepidemiology.
Related Concept Videos
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia II: Pathophysiology
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
01:30Pneumonia III: Complications and Assessment